MENU
ABOS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Acumen Pharmaceuticals (ABOS) Ownership - Who owns Acumen Pharmaceuticals?

Profile

Industry
N/A
Address
427 Park Street
Phone
+1 434 297-1000
Employees
52
Web
https://www.acumenpharm.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
194.06M
P/E Ratio
N/A
Total Cash
260.47M
Projected Growth
N/A
Total Debt
28.21M
Revenue
N/A
Risk (Beta)
-0.03
Dividend Yield
N/A
Total Cash/Share
4.34
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

ABOS
Capitalization
194M
P/E Ratio
N/A
Risk (Beta)
-0.03
Dividend Yield
N/A
Total Cash
260M
Total Cash/Share
4.34
Total Debt
28.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
244M
P/B Ratio
0.80
Cash Flow
N/A
Earnings
-1.11
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
17.37
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-62.11M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-27.82
Shares Held By Institutions
141M
Shares Outstanding - Current
60.1M
Total Liabilities
45M
Total Volume MTD
N/A
Value
-1
Gain YTD
-15.885
View a ticker or compare two or three
ABOS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
427 Park Street
Phone
+1 434 297-1000
Employees
52
Web
https://www.acumenpharm.com